Your session is about to expire
← Back to Search
Atorvastatin for Endometriosis
Study Summary
This trial will help us understand how endometriosis affects the lining of blood vessels and raises the risk for disease.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 58 Patients • NCT02084069Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are a woman between the ages of 18 and 45 who has been diagnosed with endometriosis by a laparoscopy performed by your own doctor within the last 5 years, and you have reported this diagnosis to the researchers.You have a condition or are suspected to have a condition related to your metabolism or heart health.You are using illegal drugs or taking drugs for recreational purposes.You have a skin condition, rash or known allergies related to the skin.You are not allowed to smoke or use any products containing nicotine during the study.You are pregnant.You are taking medication that affects the control of blood flow in your body, such as medications for insulin sensitivity or heart health.You are currently breastfeeding a child.You are allergic to latex or any substances being studied.
- Group 1: Atorvastatin
- Approved for 30 Other Conditions - This treatment demonstrated efficacy for 30 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are currently being monitored in this medical experiment?
"Affirmative. According to the details posted on clinicaltrials.gov, this medical trial commenced recruitment on May 1st 2018 and is currently still in progress with an update made as recently as April 8th 2022. The study seeks a total of 10 participants across one specific site location."
Is eligibility for this medical study restricted to individuals over a certain age?
"The age range of those eligible to partake in this trial is between 18 and 45 years."
What criteria must be satisfied to qualify for participation in this clinical trial?
"This research project is seeking 10 female patients aged 18-45 with a prior diagnosis of endometrioma. To be eligible, candidates must have had the condition diagnosed by laparoscopy within the last 5 years and reported to researchers."
Has Atorvastatin obtained government authorization for use?
"The safety of atorvastatin is rated a 3, signifying the trial has reached Phase 4 and the drug has been approved."
Are participants able to join this clinical research project?
"Yes, the information posted on clinicaltrials.gov demonstrates that recruitment is still ongoing for this trial. It was initially announced on May 1st 2018 and most recently updated April 8th 2022. The study intends to enrol 10 participants at a single site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger